Plasma Exosome Gene Signature Differentiates Colon Cancer from Healthy Controls.

Paul A VallejosAmber GondaJingjing YuBrittany G SullivanArsha OstowariMei Li KwongAudrey ChoiMatthew J SelleckJanviere KabagwiraRyan N FullerDaniel J GirondaEdward A LevineChristopher C W HughesNathan R WallLance D MillerMaheswari Senthil

Published in: Annals of surgical oncology (2023)

Plasma exosomal RNAs can robustly discriminate colon cancer patients, including patients with PC, from healthy controls. ExoSig445 can potentially be developed as a highly sensitive liquid biopsy test in colon cancer.

Keyphrases

genome wide
copy number
ultrasound guided
ionic liquid
fine needle aspiration
dna methylation
transcription factor
genome wide analysis